Vancouver, BC – Xenon Pharmaceuticals has been awarded the LifeSciences British Columbia Life Sciences Company of the Year Award for 2013.
“We are honored to be recognized by our industry peers in this way,” said Simon Pimstone, Xenon’s president and CEO. “This is the beginning of a very exciting year for Xenon. We’ve worked diligently and deliberately to create strong partnerships with top tier pharmaceutical companies and to develop a deep and diverse pipeline of products. One of Xenon’s early technologies is now in an approved product to treat lipoprotein lipase deficiency, we have a late stage clinical program initiating for our novel pain medicine and an early development stage product for the treatment of anemia.”